Researchers from ARADyAL analyze the management of hypersensitity to biological and chemotherapy drugs

Groups of the ARADyAL network have worked together to conduct a survey that evaluates the diagnosis and treatment of hypersensitivity reactions to chemotherapy and biological agents in Spain.

This study, which has been published in Allergy journal, show that most of the hospitals use skin test to assess both immediate non-immediate allergic reactions. You can read more here.

Tags: No tags

Comments are closed.